Similarly, in steatotic grafts from DBDs, IL-1β supplementation in the BD+IL-10+LT group (BD+IL-10+IL-1β+LT) raised IL-1β levels and abolished the benefits induced by IL-10, concerning liver injury and inflammatory response (Figures 1B, 4, 5). The gene discussed is IL1B; the disease is Behcet disease.